Items where authors include "Kietsiriroje, N."

Article

Pechlivani, N. orcid.org/0000-0001-5041-5763, Alsayejh, B., Almutairi, M.K. et al. (10 more authors) (2025) Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis. Blood Advances, 9 (1). pp. 89-100. ISSN 2473-9537

Safdar, N.Z. orcid.org/0000-0002-4232-7146, Alobaid, A.M., Hopkins, M. orcid.org/0000-0002-7655-0215 et al. (6 more authors) (2024) Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial. Diabetes, Obesity and Metabolism. ISSN 1462-8902

Campbell, M.D. orcid.org/0000-0001-5883-5041, Alobaid, A.M., Hopkins, M. orcid.org/0000-0002-7655-0215 et al. (5 more authors) (2023) Interrupting prolonged sitting with frequent short bouts of light-intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT-LESS randomised controlled trial. Diabetes, Obesity and Metabolism, 25 (12). pp. 3589-3598. ISSN 1462-8902

Ajjan, R.A., Kietsiriroje, N., Badimon, L. et al. (6 more authors) (2021) Antithrombotic therapy in diabetes: which, when, and for how long? European Heart Journal, 42 (23). pp. 2235-2259. ISSN 0195-668X

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Kietsiriroje, N. orcid.org/0000-0002-5076-4450, Badimon, L. et al. (6 more authors) (2021) Antithrombotic therapy in diabetes: which, when, and for how long? European Heart Journal, 42 (23). pp. 2235-2259. ISSN 0195-668X